Freebase cocaine in mainland France : recent trends
Tendances n°90, OFDT, 4 p.
At the end of the 2000s, the OFDT’s TREND (Emerging Trends and New Drugs) scheme, which focuses on following intense drug-using populations, revealed trends on access to freebase cocaine - including crack cocaine - and its use. These trends were practically undetectable in general population surveys. There was an observed emergence in several provincial cities of micromarkets for freebase cocaine, which was previously produced on a small scale for individual consumption. At the same time, in Paris, the crack market underwent changes in terms of both supply and demand. Given the highly addictive nature of freebase cocaine, the increased accessibility of this drug led TREND to focus on examining these market changes. To confirm and explain the observed phenomena, in 2011 and 2012, six out of the seven TREND sites (Bordeaux, Marseille, Metz, Paris, Rennes, Toulouse) conducted a specific investigation. This issue of Tendances presents the key results. These results, along with the data of the SINTES (National Detection System of Drugs and Toxic Substances) scheme make it possible to establish a report on freebase cocaine use and markets in mainland France.
Michel Gandilhon, Agnès Cadet-Taïrou, Emmanuel Lahaie
Download the PDF file (630 Ko)
Drugs in Europe
How is the COVID-19 pandemic affecting drug use, supply and services?
Drug use and harms
What are the health costs of drug use in Europe today?
What do the latest data tell us about drug production and trafficking trends?
These and other questions are explored in the 2021 European Drug Report, our annual overview of the drug situation in Europe.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format..
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.